Analysts at Jefferies Group began coverage on shares of Mattress Firm Holding Corp. (NASDAQ:MFRM) in a research report issued to clients and investors on Wednesday, American Banking News reports. The firm set a “buy” rating on the stock. Mattress Firm Holding Corp (NASDAQ:MFRM) shares after opening at $46.86on last trade day and at the end of the day closed at $47.76. Company price to sales ratio in past twelve months was calculated as 1.39 and price to cash ratio as 106.45. Mattress Firm Holding Corp (NASDAQ:MFRM) showed a positive weekly performance of 9.67%.
Oracle Corporation (NYSE:ORCL) posted higher third-quarter revenue and profit that failed to satisfy investors looking for signs of a sustained turnaround and its shares fell about 4 percent. Shareholders had grown more optimistic after Oracle’s previous quarterly results, but still worried about slow IT spending and growing competition from smaller, nimble rivals. On Tuesday, the company also forecast current-quarter results roughly in line with investors’ targets. Oracle Corporation (NYSE:ORCL) shares advanced 1.62% in last trading session and ended the day on $38.84. ORCL return on equity ratio is recorded as 25.30% and its return on assets is 13.30%. Oracle Corporation (NYSE:ORCL) yearly performance is 8.92%.
FedEx Corp. (NYSE:FDX) will be issuing its Q314 quarterly earnings data on Wednesday, March 19th. Analysts expect the company to announce earnings of $1.51 per share and revenue of $11.46 billion for the quarter. FedEx Corporation (NYSE:FDX) shares moved up 0.72% in last trading session and was closed at $138.57, while trading in range of $137.35 – $139.19. FedEx Corporation (NYSE:FDX) year to date (YTD) performance is -3.51%.
Horizon Pharma Inc (NASDAQ:HZNP) and Vidara Therapeutics International Ltd. (Vidara) announced they have entered into a definitive agreement under which Horizon Pharma will acquire Vidara through a reverse merger for stock and cash valued at approximately $660 million. Horizon Pharma plc will be the name of the resulting company. Horizon Pharma plc will be organized under the laws of Ireland with a portfolio of four products marketed primarily in the United States. The proposed transaction has been unanimously approved by both companies’ boards of directors. Pursuant to the agreement, Vidara will combine with Horizon Pharma, Inc. with approximately 74 percent of Horizon Pharma plc’s ordinary shares to be exchanged for Horizon Pharma, Inc.’s common shares, with Horizon surviving the merger. The shareholders of Vidara will retain approximately 26 percent of Horizon Pharma plc and receive $200 million in cash, subject to certain adjustments. Horizon Pharma Inc (NASDAQ:HZNP) weekly performance is 10.13%. On last trading day company shares ended up $14.68. Horizon Pharma Inc (NASDAQ:HZNP) distance from 50-day simple moving average (SMA50) is 39.74%. Analysts mean target price for the company is $18.00.